Press Releases

Hogan Lovells represents OptiNose in public offering

Philadelphia, 12 June 2018 – Hogan Lovells advised OptiNose, Inc., a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and...

Press Releases

Hogan Lovells represents Sesen Bio in public offering

Philadelphia, 6 June 2018 – Hogan Lovells advised Sesen Bio, Inc., a late-stage clinical company developing next-generation antibody-drug conjugate therapies for the treatment of...

Press Releases

Hogan Lovells advises pSivida Corp. on its acquisition of Icon Bioscience as it rebrands as EyePoint Pharmaceuticals

Philadelphia, 4 April 2018 – Hogan Lovells advised pSivida Corp. on its acquisition of Icon Bioscience, Inc. as part of its rebranding initiative into EyePoint Pharmaceuticals, Inc....

Loading data